Cleared Traditional

K920915 - CAPNOMED 100 STAND-ALONE ETCO2 MODULE

K920915 is an FDA 510(k) clearance for CAPNOMED 100 STAND-ALONE ETCO2 MODULE, manufactured by Mennen Medical, Inc.. The device is a Class 2 Anesthesiology device with product code CCK cleared through the Traditional 510(k) pathway after a 390-day FDA review.

K920915 · Mennen Medical, Inc. · Anesthesiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 1993
Decision
390d
Days
Class 2
Risk

K920915 is an FDA 510(k) clearance for the CAPNOMED 100 STAND-ALONE ETCO2 MODULE. Classified as Analyzer, Gas, Carbon-dioxide, Gaseous-phase (product code CCK), Class II - Special Controls.

Submitted by Mennen Medical, Inc. (Clarence, US). The FDA issued a Cleared decision on March 23, 1993 after a review of 390 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.1400 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the Anesthesiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Mennen Medical, Inc. devices

FDA 510(k) Submission Details - K920915

510(k) Number K920915 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 27, 1992
Decision Date March 23, 1993
Days to Decision 390 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
250d slower than avg
Panel avg: 140d · This submission: 390d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

CCK Device Classification - Class 2, Special Controls

Product Code CCK Analyzer, Gas, Carbon-dioxide, Gaseous-phase
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.1400
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - CCK Analyzer, Gas, Carbon-dioxide, Gaseous-phase

All 243
Devices cleared under the same product code (CCK) and FDA review panel - the closest regulatory comparables to K920915.
VITALMAX 800-C
K930559 · Pace Tech, Inc. · Sep 1993
NELLCOR STAT-CAP AIRWAY CO2 INDICATOR, MODEL N-60
K915494 · Nellcor, Inc. · Aug 1993
RASCAL II
K930866 · Ohmeda Medical · May 1993
MASS SPECTROMETRY MONITORING LINE CONONECTORS
K925167 · Merit Medical Systems, Inc. · Jan 1993
VITALERT 3000 MONITORING SYSTEM
K913995 · Draeger Medical, Inc. · Nov 1992
DATASCOPE PASSPORT MONITOR WITH CO2
K921526 · Datascope Corp. · Oct 1992